The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Free radicals, antioxidant defense systems, and schizophrenia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Nordberg, J., & Arnér, E. S. J. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00724-9 · Cited by 2,662
Kohen, R., & Nyska, A. (2002) · Toxicologic Pathology · doi:10.1080/01926230290166724 · Cited by 2,178
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020 · cited 1×
“…hypothesis for the etiology of schizophrenia is that variations inmultiple risk genes, each with a modest additive consequence, interacting with environmental and developmental factors, contribute to the disease phenotype (Harrison and Weinberger, 2005; Lohmueller et al., 2003; Weinberger, 1987).”
BackgroundFree radical-mediated oxidation of free amino acids and amino acid residues in proteins
Stadtman, E. R., & Levine, R. L. (2003) · Amino Acids · doi:10.1007/s00726-003-0011-2 · Cited by 1,962
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Biochemistry of oxidative stress
Halliwell, B. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351147 · Cited by 1,543
Oxidative stress: the paradox of aerobic life
Davies, K. J. A. (1995) · Biochemical Society Symposia · doi:10.1042/bss0610001 · Cited by 1,146
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069
Griendling, K. K., Sorescu, D., Lassègue, B., & Ushio-Fukai, M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2175 · Cited by 955
Transition metals as catalysts of “autoxidation” reactions
Miller, D. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90148-c · Cited by 739 · cited 1×
“The free radical species include reactive oxygen species (ROS), reactive nitrogen species (NOS), carbon-centered radicals, and sulfur-centered radicals (Miller et al., 1990).”
BackgroundGawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000805 · Cited by 594
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540
Oxidative stress in schizophrenia: An integrated approach
Bitanihirwe, B. K. Y., & Woo, T.-U. W. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.008 · Cited by 472
Ranjekar, P. K., Hinge, A., Hegde, M. V., Ghate, M., Kale, A., Sitasawad, S., Wagh, U. V., Debsikdar, V. B., & Mahadik, S. P. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00220-8 · Cited by 395
Lipid Peroxidation and Mechanisms of Toxicity
Horton, A. A., Fairhurst, S., & Bus, J. S. (1987) · CRC Critical Reviews in Toxicology · doi:10.3109/10408448709089856 · Cited by 339
Altered glutathione redox state in schizophrenia.
Yao, J. K., Leonard, S., & Reddy, R. (2006) · Disease Markers · doi:10.1155/2006/248387 · Cited by 321
Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder
Kuloglu, M., Ustundag, B., Atmaca, M., Canatan, H., Tezcan, A. E., & Cinkilinc, N. (2002) · Cell Biochemistry and Function · doi:10.1002/cbf.940 · Cited by 321
Schizophrenia: A New Approach. II. Result of a Year's Research
Hoffer, A., Osmond, H., & Smythies, J. (1954) · Journal of Mental Science · doi:10.1192/bjp.100.418.29 · Cited by 298
Antioxidants, Redox Signaling, and Pathophysiology in Schizophrenia: An Integrative View
Yao, J. K., & Keshavan, M. S. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3603 · Cited by 285
An update on the role of free radicals and antioxidant defense in human disease
Vendemiale, G., Grattagliano, I., & Altomare, E. (1999) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990050063 · Cited by 269
Zhang, X. Y., Tan, Y. L., Cao, L. Y., Wu, G. Y., Xu, Q., Shen, Y., & Zhou, D. F. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.10.011 · Cited by 262
Self-citationPhenotype of schizophrenia: a review and formulation
Tamminga, C. A., & Holcomb, H. H. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001563 · Cited by 262
Morgenstern, H. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820210057007 · Cited by 260
Markers of Glutamatergic Neurotransmission and Oxidative Stress Associated With Tardive Dyskinesia
Tsai, G., Goff, D. C., Chang, R. W., Flood, J., Baer, L., & Coyle, J. T. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1207 · Cited by 243
Herken, H., Uz, E., Özyurt, H., Söğüt, S., Virit, O., & Akyol, Ö. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000789 · Cited by 238
Mahadik, S. P., Evans, D., & Lal, H. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00181-0 · Cited by 229
Parikh, V., Khan, M. M., & Mahadik, S. P. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00048-1 · Cited by 224
Oxygen Radicals and Neuropsychiatric Illness: Some Speculations
Lohr, J. B. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810360061009 · Cited by 224
Berg, D., Youdim, M. B. H., & Riederer, P. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0976-5 · Cited by 220
Matsuzawa, D., Obata, T., Shirayama, Y., Nonaka, H., Kanazawa, Y., Yoshitome, E., Takanashi, J., Matsuda, T., Shimizu, E., Ikehira, H., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001944 · Cited by 201
Free radical pathology in schizophrenia: a review
Reddy, R. D., & Yao, J. K. (1996) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90143-x · Cited by 201
Reduced plasma antioxidants in first-episode patients with schizophrenia
Reddy, R. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00407-3 · Cited by 194
Phagocyte-derived reactive species: salvation or suicide?
Halliwell, B. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.07.005 · Cited by 192
The many faces of nitric oxide in schizophrenia. A review
Bernstein, H.-G., Bogerts, B., & Keilhoff, G. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.05.019 · Cited by 181
A meta-analysis of oxidative stress markers in schizophrenia
Zhang, M., Zhao, Z., He, L., & Wan, C. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-0013-8 · Cited by 173
Padurariu, M., Ciobica, A., Dobrin, I., & Stefanescu, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.05.088 · Cited by 171
Lohr, J. B., Kuczenski, R., Bracha, H. S., Moir, M., & Jeste, D. V. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90490-s · Cited by 171
Abdalla, D. S., Monteiro, H. P., Oliveira, J. A., & Bechara, E. J. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.5.805 · Cited by 168
Raffa, M., Atig, F., Mhalla, A., Kerkeni, A., & Mechri, A. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-124 · Cited by 167
Enzymes of the antioxidant defense system in chronic schizophrenic patients
Reddy, R. D., Mahadik, S. P., Mukherjee, S., & Murthy, J. N. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90298-z · Cited by 165
Elevated Plasma Lipid Peroxides at the Onset of Nonaffective Psychosis
Mahadik, S. P., Mukherjee, S., Scheffer, R., Correnti, E. E., & Mahadik, J. S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00282-5 · Cited by 163
Reduced status of plasma total antioxidant capacity in schizophrenia
Yao, J. K., Reddy, R., McElhinny, L. G., & van Kammen, D. P. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00030-9 · Cited by 161
Impaired antioxidant defense at the onset of psychosis
Mukherjee, S., Mahadik, S. P., Scheffer, R., Correnti, E. E., & Kelkar, H. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00048-8 · Cited by 161
Pillai, A., Parikh, V., Terry, A. V., & Mahadik, S. P. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.01.011 · Cited by 153
Treatment of tardive dyskinesia with vitamin E
Egan, M. F., Hyde, T. M., Albers, G. W., Elkashef, A. M., Alexander, R. C., Reeve, A., Blum, A., Sáenz, R. E., & Wyatt, R. J. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.6.773 · Cited by 148
Increased pentane and carbon disulfide in the breath of patients with schizophrenia.
Phillips, M., Sabas, M., & Greenberg, J. H. (1993) · Journal of Clinical Pathology · doi:10.1136/jcp.46.9.861 · Cited by 148
Abnormal age-related changes of plasma antioxidant proteins in schizophrenia
Yao, J. K., Reddy, R. D., & van Kammen, D. P. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00230-4 · Cited by 143
Vitamin E treatment of tardive dyskinesia
Adler, L. A., Peselow, E. D., Rotrosen, J., Duncan, E., Lee, M., Rosenthal, M., & Angrist, B. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.9.1405 · Cited by 142
Oxidative stress in schizophrenia - focusing on the main markers.
Ciobica, A. S., Pădurariu, M., Dobrin, I., Ștefănescu, C., & Dobrin, R. (2011) · PubMed · Cited by 140
Altuntaş, İ., Aksoy, H., Coşkun, İ., Çayköylü, A., & Akçay, F. (2000) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2000.201 · Cited by 134
Manganese Superoxide Dismutase Gene Polymorphism and Schizophrenia Relation to Tardive Dyskinesia
Hori, H. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00156-6 · Cited by 130
Gama, C. S., Salvador, M. M., Andreazza, A. C., Kapczinski, F. P., & Belmonte-de-Abreu, P. S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.009 · Cited by 129
Effects of haloperidol on antioxidant defense system enzymes in schizophrenia
Yao, J. K., Reddy, R. D., McElhinny, L. G., & van Kammen, D. P. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)00028-4 · Cited by 127
Reduced level of plasma antioxidant uric acid in schizophrenia
Yao, J. K., Reddy, R. D., & van Kammen, D. P. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(98)00051-1 · Cited by 121
Reduced antioxidant defense in early onset first-episode psychosis: a case-control study
Micó, J. A., Rojas-Corrales, M. O., Gibert‐Rahola, J., Parellada, M., Moreno, D. M., Fraguas, D., Graell, M., Gil, J., Irazusta, J., Castro‐Fornieles, J., et al. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-26 · Cited by 118
Crow, T. J., Cross, A. J., Johnstone, E. C., Owen, F., Owens, D. G. C., & Waddington, J. L. (1982) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198210000-00010 · Cited by 111
Association between Ala–9Val polymorphism of Mn-SOD gene and schizophrenia
Akyol, Ö., Yanık, M., Elyas, H., Namlı, M. N., Canatan, H., Akın, H., Yüce, H., Yilmaz, H. R., Tutkun, H., Söğüt, S., et al. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.10.014 · Cited by 107
Medial temporal lobe glutathione concentration in first episode psychosis: A 1H-MRS investigation
Wood, S. J., Berger, G. E., Wellard, R. M., Proffitt, T., McConchie, M., Berk, M., McGorry, P. D., & Pantelis, C. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.018 · Cited by 107
A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
Lohr, J. B., & Caligiuri, M. P. (1996) · PubMed · Cited by 105
Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment
Peet, M., Laugharne, J. D. E., Rangarajan, N., & Reynolds, G. P. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00003 · Cited by 103
Free radical involvement in neuropsychiatric illnesses.
Jb, L., & Ja, B. (1995) · PubMed · Cited by 102
Extract of Ginkgo biloba Treatment for Tardive Dyskinesia in Schizophrenia
Zhang, W.-F., Tan, Y.-L., Zhang, X., Chan, R. C. K., Wu, H.-R., & Zhou, D.-F. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05125yel · Cited by 98
Self-citationTerpstra, M., Vaughan, T. J., Uǧurbil, K., Lim, K. O., Schulz, S. C., & Rolf Gruetter, A. (2005) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-005-0012-0 · Cited by 98
Sarandöl, A., Kırlı, S., Akkaya, C., Altın, A., Demirci, M., & Sarandöl, E. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.03.008 · Cited by 98
Long-term treatment effects of vitamin E for tardive dyskinesia
Adler, L. A., Edson, R., Lavori, P. W., Peselow, E. D., Duncan, E., Rosenthal, M., & Rotrosen, J. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00027-9 · Cited by 83
The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients
Zhang, X., Chen, D. C., Xiu, M. H., Wang, F., Qi, L. Y., Sun, H. Q., Chen, S., He, S. C., Wu, G. Y., Haile, C. N., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.05.016 · Cited by 82
Self-citationOxidative Stress in Schizophrenia: Pathogenetic and Therapeutic Implications
Yao, J. K., & Reddy, R. D. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3646 · Cited by 80
H2O2-induced higher order chromatin degradation: A novel mechanism of oxidative genotoxicity
Konat, G. W. (2003) · Journal of Biosciences · doi:10.1007/bf02970132 · Cited by 79
McCreadie, R. G., MacDonald, E., Wiles, D. H., Campbell, G. R., & Paterson, J. R. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.167.5.610 · Cited by 78
Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia
Zhang, X., Zhou, D. F., Shen, Y., Zhang, P. Y., Zhang, W. F., Liang, J., Chen, D. C., Xiu, M. H., Kosten, T. A., & Kosten, T. R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.014 · Cited by 74
Self-citationVitamin C status in chronic schizophrenia
Subotičanec, K., Folnegović-Šmalc, V., Korbar, M., Mestrovic, B., & Buzina, R. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90061-6 · Cited by 71
Zhang, X., Zhou, D. F., Cao, L. Y., Zhang, P. Y., & Wu, G. Y. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(02)00303-7 · Cited by 71
Self-citationZhang, X., Tan, Y. L., Zhou, D. F., Cao, L. Y., Wu, G. Y., Haile, C. N., Kosten, T. A., & Kosten, T. R. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0513 · Cited by 70
Self-citationHuman plasma glutathione peroxidase and symptom severity in schizophrenia
Yao, J. K., Reddy, R. D., & van Kammen, D. P. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00184-x · Cited by 69
Glutathione peroxidase and CT scan abnormalities in schizophrenia
Buckman, T. D., Kling, A. S., Eiduson, S., Sutphin, M. S., & Steinberg, A. M. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90069-2 · Cited by 68
Buckman, T. D., Kling, A. S., Sutphin, M. S., Steinberg, A., & Eiduson, S. (1990) · Psychiatry Research · doi:10.1016/0165-1781(90)90103-c · Cited by 67
A Defect in the Antioxidant Defense System in Schizophrenia
Vırıt, O., Altındağ, A., Yumru, M., Dalkiliç, A., SAVAS, H. A., Selek, Ş., Erel, Ö., & Herken, H. (2009) · Neuropsychobiology · doi:10.1159/000239684 · Cited by 63
Isoprostenes as indicators of oxidative stress in schizophrenia
Dietrich‐Muszalska, A., & Olas, B. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701361263 · Cited by 62
The Effect of Risperidone Treatment on Superoxide Dismutase in Schizophrenia
Zhang, X., Zhou, D. F., Cao, L. Y., Zhang, P. Y., Wu, G. Y., & Shen, Y. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00004 · Cited by 61
Self-citationReduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia
Li, X. F., Zheng, Y. L., Xiu, M. H., Chen, D. C., Kosten, T. R., & Zhang, X. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.001 · Cited by 60
Self-citationLee, B.-H., & Kim, Y. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.06.005 · Cited by 60
Carpenter, W. T. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.3.327 · Cited by 59
Wu, Z., Zhang, X., Wang, H., Tang, W., Xia, Y., Zhang, F., Liu, J., Fu, Y., Hu, J., Chen, Y., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.08.018 · Cited by 58
Self-citationZai, C. C. H., Tiwari, A. K., Basile, V. S., Luca, V. D., Müller, D. J., Voineskos, A. N., Remington, G. J., Meltzer, H. Y., Lieberman, J. A., Potkin, S. G., et al. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.09.020 · Cited by 57
Redox Control of Protein Degradation
Lockwood, T. D. (2000) · Antioxidants and Redox Signaling · doi:10.1089/ars.2000.2.4-851 · Cited by 50
Hitzeroth, A., Niehaus, D. J. H., Koen, L., Botes, W. C., Deleuze, J., & Warnich, L. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.12.019 · Cited by 45
Antioxidant Therapeutics for Schizophrenia
Reddy, R. D., & Reddy, R. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3571 · Cited by 44
Long-term effects of newer antipsychotic drugs on neuronal nitric oxide synthase in rat brain
Tarazi, F. I., Zhang, K., & Baldessarini, R. J. (2002) · Nitric Oxide · doi:10.1016/s1089-8603(02)00126-x · Cited by 35
Elevated neuronal nitric oxide synthase expression in chronic haloperidol-treated rats
Lau, Y. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00314-9 · Cited by 35
Yamada, K., Kanba, S., Anamizu, S., OHNISHI, K., Ashikari, I., Yagi, G., & Asai, M. (1997) · Psychological Medicine · doi:10.1017/s0033291797005114 · Cited by 35
Shinkai, T., Müller, D. J., Luca, V. D., Shaikh, S. A., Matsumoto, C., Hwang, R., King, N. A., Trakalo, J., Potapova, N., Zai, G. C., et al. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2004.06.023 · Cited by 34
Kang, S., Choi, J., An, H., Park, Y., Lee, H., Han, C., Kim, Y., Kim, S., Cho, S. N., Joe, S., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.08.013 · Cited by 31
Shinkai, T., Luca, V. D., Zai, G. C., Shaikh, S. A., Matsumoto, C., Arnold, P. D., Hwang, R., King, N. A., Trakalo, J., Potapova, N., et al. (2004) · Psychiatric Genetics · doi:10.1097/00041444-200409000-00012 · Cited by 15
[Glutathione peroxidase activity in the blood in chronic schizophrenia].
Stoklasova, A., Zapletálek, M., Kudrnová, K., & Randová, Z. (1986) · PubMed · Cited by 12
[Analysis of platelet superoxide dismutase 1 in the development of childhood psychoses].
Golse, B., Debray-Ritzen, P., Puget, K., & Michelson, A. M. (1977) · PubMed · Cited by 11
Cited by
Oxidative Stress: Harms and Benefits for Human Health
Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., & Bitto, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8416763 · Cited by 4,837
Oxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979
“The non-enzymatic antioxidants are molecules that interact with RONS and terminate the free radical chain reactions: bilirubin, α-tocopherol (vitamin E), and β-carotene are present in blood while albumin and uric acid account for 85% of antioxidant capacity in plasma.(15) • Exogenous antioxidants include ascorbic acid…”
BackgroundReactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Oxidative Stress and the Central Nervous System
Salim, S. (2017) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.237503 · Cited by 1,247
Endogenous non-enzymatic antioxidants in the human body
Mirończuk-Chodakowska, I., Witkowska, A. M., & Zujko, M. E. (2018) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.05.005 · Cited by 613
Metadata
- Authors
- Wu, J. Q., Kosten, T. R., & Zhang, X. Y.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 46
- Pages
- 200-206
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2094905804
- Cited by
- 424
- References
- 97
- FWCI
- 14.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.